PublizoomAward notice Supplies
Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- HUmani SC
Charleroi - Place of performance
- 6042 Lodelinsart, Hainaut
- Amount awarded
- €832,552 excl. VAT
- Planned end of contract
- 1 December 2027
likely re-tender around June 2027 - Bids received
- 7
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 12 January 2024
- Notice language
- French
What is the authority looking for?
Supplies · Produits pharmaceutiques, vaccins
Le présent marché à lots a pour objet la fourniture d'anastroazole, d'anaglélide, de létrozole, de bévacizumab, de bortézomib et de fulvestrant dans différents dosages et formes galéniques.
Where and when?
6042 Lodelinsart, Hainaut
Deadline not published in the notice
Site visit and deadline for questions: stated in the specifications, not in the notice.
What budget?
Amount not published in the notice. The AI analysis and comparable tenders give an order of magnitude.
Why is this tender relevant to me?
Create your free account : we compare every tender with your trade and your area.
Can I consider bidding?
The AI analysis extracts the participation conditions, the contractor approval and the required documents. See the analysis and the verdict for your company
Nothing is assumed: what the notice does not say is marked "to check".
What do I need to do?
1. Read the analysis · 2. Check that you meet the conditions · 3. Prepare the response · 4. Submit on the official platform before the deadline.
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le présent marché à lots a pour objet la fourniture d'anastroazole, d'anaglélide, de létrozole, de bévacizumab, de bortézomib et de fulvestrant dans différents dosages et formes galéniques.
Awarded to
6 lots
- Anastrozole - Per os
- Anagrélide - Per os
- Létrozole - per os
- Bevacizumab - Injectable
- Bortézomib - Injectable
- Fulvestrant - injectable
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Fourniture d’acide zolédronique, concentré de complexe prothrombinique et fibrinogène HUmani SC · 5 March 2026 |
PHARMANOVIA BENELUX B.V. OCTAPHARMA BENELUX SA |
€954,778 |
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Raamovereenkomst voor het leveren van Tocilizumab IV AZ Oudenaarde · 16 October 2026 |
Fresenius Kabi | €1,200,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
| Leveren van parenterale en inhalatie antibiotica UZ Leuven · 12 October 2026 |
sandoz Viatris Fresenius Kabi ACCORD HEALTHCARE |
€26,847,462 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 22439-2024.